Home >
Research & Grants >
Awards and Scholarships > Congratulations to the 2012 Brinker Awardees
Congratulations to the 2012 Brinker Awardees
| Congratulations to our 2012 Brinker Awardees! These prominent physician-scientists are honored for their groundbreaking work which have unraveled the biology of breast cancer and improved the quality of life for breast cancer survivors. They will deliver keynote lectures December 5 at the 35th annual San Antonio Breast Cancer Symposium, a major international gathering of breast cancer researchers, clinicians, and patient advocacy organizations from around the world being held Dec. 4-8 in San Antonio, Texas. |
| |
 |
Prof. Yosef Yarden, Ph.D.
Department of Biological Regulation
Weizmann Institute of Science
Rehovot, Israel
|
Prof. Yarden is receiving the Brinker Award for Scientific Distinction in Basic Science for his extensive contributions to breast cancer research, which have been instrumental in advancing our understanding of the biology of growth factors and their receptors, and their role in human cancers. His research has been crucial to establishing growth factor receptors—particularly the HER2 receptor—as prime targets for cancer drugs. Prof. Yarden’s pioneering work in growth factor receptor signaling and regulation has helped unravel the role of growth factors in cancer and laid the foundation for the development of cancer drugs that target growth factor receptors. His work will have a lasting impact on breast cancer research and treatment for years to come. Read full bio here .
|
|
Dr. Hyman B. Muss, M.D.
Lineberger Comprehensive Cancer Center
The University of North Carolina, Chapel Hill
Chapel Hill, North Carolina
|
Dr. Muss is receiving the Brinker Award for Scientific Distinction in Clinical Research for his critical contributions to the treatment of breast cancer, in particular the treatment of breast cancer in older women. His work on clinical trials specifically targeted to older women has provided the foundation for offering geriatric patients state-of-the art treatments and has had a significant impact on the standard of care and quality of life for elderly women with breast cancer. Dr. Muss’ research has brought attention to the issues specific to elderly breast cancer patients and has advanced the clinical care of this special population of patients. His work is improving the lives of countless women every year, and his impact on the breast cancer community will be felt for years to come.Read full bio here.
|
To view the press release for the 2012 Brinker Awardees, please click here.
|
| |
|
| |
|
